Gilead Sciences Inc on Monday priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed to send nearly all of its supply of the drug to the United States over the...
from NDTV News - World-news https://ift.tt/3dKZIH5
Resent New
Discord abandons Microsoft acquisition talks: Report
Discussion platform Discord, popular among amateur video game players, has halted acquisition talks with Microsoft and is instead considerin...
